⌕
West Pharmaceutical Services · WST · NYSE
Tenet 48 · Mixed
Compare
$416.42+1.24%At closeTenet 48 · Mixed
$416.42+5.12 (+1.24%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD
$417.00+0.58 (+0.14%)
Pre-market: Nov 16, 2026, 8:00 AM ET· last 1-minute bar

West Pharmaceutical Services (WST) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 139 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 841 filers, Jun 30, 2026
# 13F FUNDS
841
13F VALUE
$25.4B
70.8M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 30, 2026HAUGEN JANET BRUTSCHEAdirectorAcquired · Grant / award44Phantom Stock Unit$370.76↗
Sep 15, 2026Favorite Annette FSr. VP & Chief HR OfficerAcquired · Option exercise2,524$89.64↗
Sep 15, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Open-market sale2,524$365.00↗
Sep 15, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Option exercise2,524Stock Option (Right to Buy)—↗
Sep 14, 2026Favorite Annette FSr. VP & Chief HR OfficerAcquired · Option exercise2,500$89.64↗
Sep 14, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Open-market sale2,500$355.00↗
Sep 14, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Option exercise2,500Stock Option (Right to Buy)—↗
Sep 11, 2026Favorite Annette FSr. VP & Chief HR OfficerAcquired · Option exercise2,500$89.64↗
Sep 11, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Open-market sale2,500$345.00↗
Sep 11, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Option exercise2,500Stock Option (Right to Buy)—↗
Sep 8, 2026Lagarde MichelPresident and CEOAcquired · Grant / award13,879Stock Option (Right to Buy)—↗
Sep 8, 2026Lagarde MichelPresident and CEOAcquired · Grant / award11,081Stock Option (Right to Buy)—↗
Sep 8, 2026Lagarde MichelPresident and CEOAcquired · Grant / award12,088Stock Option (Right to Buy)—↗
Sep 8, 2026Lagarde MichelPresident and CEOAcquired · Grant / award6,200Rst. Stock Unit—↗
Sep 8, 2026Lagarde MichelPresident and CEOAcquired · Grant / award4,950Rst. Stock Unit—↗
Sep 8, 2026Lagarde MichelPresident and CEOAcquired · Grant / award3,600Rst. Stock Unit—↗
Sep 8, 2026Favorite Annette FSr. VP & Chief HR OfficerAcquired · Option exercise2,817$83.47↗
Sep 8, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Open-market sale2,817$340.81↗
Sep 8, 2026Favorite Annette FSr. VP & Chief HR OfficerAcquired · Option exercise2,818$83.47↗
Sep 8, 2026Favorite Annette FSr. VP & Chief HR OfficerDisposed · Open-market sale2,818$340.81↗

* Holdings as reported for Jun 30, 2026, 139 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold West Pharmaceutical Services?

West Pharmaceutical Services was held by 841 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.